港交所(00388.HK)任命楊秋梅為行政總裁顧問及董事總經理
香港交易所(00388.HK)宣布任命楊秋梅為集團行政總裁顧問及董事總經理。她將與港交所的內地業務發展和客戶發展部門合作,協助管理團隊推行各項內地發展戰略,同時負責管理集團的中國內地子公司。
她還將負責管理集團行政總裁辦公室的工作,向集團行政總裁歐冠昇匯報。
楊秋梅於2013至2018年擔任全球基金經理人的行業協會(ICI Global)的亞太區首席執行官。此前,她於2010至2013年擔任港交所內地業務發展主管和市場發展副主管。在加入港交所之前,她曾擔任中國證監會基金部副主任。她在2000年加入中國證監會,曾任該會規劃發展委員會委員及國際部副主任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.